相关实验视频

Updated: May 5, 2026

Stereotactic Radiosurgery for Gynecologic Cancer

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

在肺癌中,整合立体性除性辐射疗法技术与高分离的潜力

Chi-Chuan Chiou¹, Yuan-Hung Wu^1,2,3,4, Pin-I Huang^1,2

¹Department of Heavy Particles and Radiation Oncology, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.

Thoracic cancer

|June 17, 2024

概括

具有高分离的立体除性放射疗法 (SABR) 显示出肺癌治疗的潜力,在高剂量区域提供优势,但在低剂量区域存在缺点. 需要进一步的研究来比较低分和高分的有效性.

科学领域:

辐射瘤学辐射瘤学
医学物理医学物理

背景情况:

有限的研究存在于整合立体性除性放射疗法 (SABR) 与肺癌的高分离疗法.
这项研究调查了SABR与高分离的潜力,以减少肺毒性.

研究的目的:

评估SABR的可行性和有效性,以减少早期肺癌患者的肺毒性.
通过最大限度地提高瘤与正常组织的生物等效剂量 (BED) 比率来确定最佳的分化策略.

主要方法:

用于计算最佳瘤BED与正常组织BED比率的线性二次模型.
在10名早期肺癌患者中,SABR计划 (50 Gy/5分) 与高分计划 (88.8 Gy/74分) 的比较.
使用威尔科克森签名等级试验评估平均肺BED,NTCP,临界体积标准和V20.

主要成果:

与低分数治疗方案相比,高分数治疗方案显示了较低的平均肺BED (6.40 Gy vs. 7.73 Gy) 和NTCP (3.50% vs. 4.21%) 与低分数治疗方案相比.
在高剂量区域中,高分离率优于高剂量区域,但在低剂量区域下降,V20较高 (7.37%对比7.03%).
在肺BED,NTCP,CV标准和V20 (p < 0.01) 中观察到显著差异.

结论:

过分分的SABR在高剂量肺部区域具有优势,但在低剂量区域具有缺点.
这项研究突出了一个过渡点,影响了hypo-vs-hyperfractionation的优越性.
需要进行进一步的研究,以确定低分或高分化在肺癌治疗中的优势.

关键词:

在NTCP中,NTCP是NTCP.SABR SABR是一款 SABR 系列的汽车.临界体积的临界体积是一个临界体积.过分分化的超分化.肺癌是一种肺癌.

更多相关视频

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.